Skip to main content
Erschienen in: Updates in Surgery 1/2022

18.05.2021 | Original Article

Prognosis prediction of extremity and trunk wall soft-tissue sarcomas treated with surgical resection with radiomic analysis based on random survival forest

verfasst von: Yuhan Yang, Xuelei Ma, Yixi Wang, Xinyan Ding

Erschienen in: Updates in Surgery | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Abstract

Many researches have applied machine learning methods to find associations between radiomic features and clinical outcomes. Random survival forests (RSF), as an accurate classifier, sort all candidate variables as the rank of importance values. There was no study concerning on finding radiomic predictors in patients with extremity and trunk wall soft-tissue sarcomas using RSF. This study aimed to determine associations between radiomic features and overall survival (OS) by RSF analysis. To identify radiomic features with important values by RSF analysis, construct predictive models for OS incorporating clinical characteristics, and evaluate models’ performance with different method. We collected clinical characteristics and radiomic features extracted from plain and contrast-enhanced computed tomography (CT) from 353 patients with extremity and trunk wall soft-tissue sarcomas treated with surgical resection. All radiomic features were analyzed by Cox proportional hazard (CPH) and followed RSF analysis. The association between radiomics-predicted risks and OS was assessed by Kaplan–Meier analysis. All clinical features were screened by CPH analysis. Prognostic clinical and radiomic parameters were fitted into RSF and CPH integrative models for OS in the training cohort, respectively. The concordance indexes (C-index) and Brier scores of both two models were evaluated in both training and testing cohorts. The model with better predictive performance was interpreted with nomogram and calibration plots. Among all 86 radiomic features, there were three variables selected with high importance values. The RSF on these three features distinguished patients with high predicted risks from patients with low predicted risks for OS in the training set (P < 0.001) using Kaplan–Meier analysis. Age, lymph node involvement and grade were incorporated into the combined models for OS (P < 0.05). The C-indexes in both two integrative models fluctuated above 0.80 whose Brier scores maintained less than 15.0 in the training and testing datasets. The RSF model performed little advantages over the CPH model that the calibration curve of the RSF model showed favorable agreement between predicted and actual survival probabilities for the 3-year and 5-year survival prediction. The multimodality RSF model including clinical and radiomic characteristics conducted high capacity in prediction of OS which might assist individualized therapeutic regimens. Level III, prognostic study.
Literatur
1.
Zurück zum Zitat Gutierrez JC, Perez EA, Franceschi D, Moffat FL Jr, Livingstone AS, Koniaris LG (2007) Outcomes for soft-tissue sarcoma in 8249 cases from a large state cancer registry. J Surg Res 141(1):105–114CrossRef Gutierrez JC, Perez EA, Franceschi D, Moffat FL Jr, Livingstone AS, Koniaris LG (2007) Outcomes for soft-tissue sarcoma in 8249 cases from a large state cancer registry. J Surg Res 141(1):105–114CrossRef
2.
Zurück zum Zitat Crago AM, Brennan MF (2015) Principles in management of soft tissue sarcoma. Adv Surg 49(1):107–122CrossRef Crago AM, Brennan MF (2015) Principles in management of soft tissue sarcoma. Adv Surg 49(1):107–122CrossRef
3.
Zurück zum Zitat Miwa S, Yamamoto N, Hayashi K, Takeuchi A, Igarashi K, Tsuchiya H (2019) Therapeutic targets for bone and soft-tissue sarcomas. Int J Mol Sci. 20(1):1CrossRef Miwa S, Yamamoto N, Hayashi K, Takeuchi A, Igarashi K, Tsuchiya H (2019) Therapeutic targets for bone and soft-tissue sarcomas. Int J Mol Sci. 20(1):1CrossRef
4.
Zurück zum Zitat Patel DB, Matcuk GR Jr (2018) Imaging of soft tissue sarcomas. Chin Clin Oncol 7(4):35CrossRef Patel DB, Matcuk GR Jr (2018) Imaging of soft tissue sarcomas. Chin Clin Oncol 7(4):35CrossRef
5.
Zurück zum Zitat Aerts HJ, Velazquez ER, Leijenaar RT, Parmar C, Grossmann P, Carvalho S, Bussink J, Monshouwer R, Haibe-Kains B, Rietveld D, Hoebers F, Rietbergen MM, Leemans CR, Dekker A, Quackenbush J, Gillies RJ, Lambin P (2014) Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun 5:4006CrossRef Aerts HJ, Velazquez ER, Leijenaar RT, Parmar C, Grossmann P, Carvalho S, Bussink J, Monshouwer R, Haibe-Kains B, Rietveld D, Hoebers F, Rietbergen MM, Leemans CR, Dekker A, Quackenbush J, Gillies RJ, Lambin P (2014) Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun 5:4006CrossRef
6.
Zurück zum Zitat Gillies RJ, Kinahan PE, Hricak H (2016) Radiomics: images are more than pictures, they are data. Radiology 278(2):563–577CrossRef Gillies RJ, Kinahan PE, Hricak H (2016) Radiomics: images are more than pictures, they are data. Radiology 278(2):563–577CrossRef
7.
Zurück zum Zitat Lambin P, Leijenaar RTH, Deist TM, Peerlings J, de Jong EEC, van Timmeren J, Sanduleanu S, Larue R, Even AJG, Jochems A, van Wijk Y, Woodruff H, van Soest J, Lustberg T, Roelofs E, van Elmpt W, Dekker A, Mottaghy FM, Wildberger JE, Walsh S (2017) Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol 14(12):749–762CrossRef Lambin P, Leijenaar RTH, Deist TM, Peerlings J, de Jong EEC, van Timmeren J, Sanduleanu S, Larue R, Even AJG, Jochems A, van Wijk Y, Woodruff H, van Soest J, Lustberg T, Roelofs E, van Elmpt W, Dekker A, Mottaghy FM, Wildberger JE, Walsh S (2017) Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol 14(12):749–762CrossRef
8.
Zurück zum Zitat O’Sullivan F, Roy S, O’Sullivan J, Vernon C, Eary J (2005) Incorporation of tumor shape into an assessment of spatial heterogeneity for human sarcomas imaged with FDG-PET. Biostatistics 6(2):293–301CrossRef O’Sullivan F, Roy S, O’Sullivan J, Vernon C, Eary J (2005) Incorporation of tumor shape into an assessment of spatial heterogeneity for human sarcomas imaged with FDG-PET. Biostatistics 6(2):293–301CrossRef
9.
Zurück zum Zitat Skamene SR, Rakheja R, Dahlstrom KR, Roberge D, Nahal A, Charest M, Turcotte R, Hickeson M, Freeman C (2014) Metabolic activity measured on PET/CT correlates with clinical outcomes in patients with limb and girdle sarcomas. J Surg Oncol 109(5):410–414CrossRef Skamene SR, Rakheja R, Dahlstrom KR, Roberge D, Nahal A, Charest M, Turcotte R, Hickeson M, Freeman C (2014) Metabolic activity measured on PET/CT correlates with clinical outcomes in patients with limb and girdle sarcomas. J Surg Oncol 109(5):410–414CrossRef
10.
Zurück zum Zitat Wolsztynski E, O’Sullivan F, Keyes E, O’Sullivan J, Eary JF (2018) Positron emission tomography-based assessment of metabolic gradient and other prognostic features in sarcoma. J Med Imaging (Bellingham) 5(2):024502 Wolsztynski E, O’Sullivan F, Keyes E, O’Sullivan J, Eary JF (2018) Positron emission tomography-based assessment of metabolic gradient and other prognostic features in sarcoma. J Med Imaging (Bellingham) 5(2):024502
11.
Zurück zum Zitat Spraker MB, Wootton LS, Hippe DS, Ball KC, Peeken JC, Macomber MW, Chapman TR, Hoff MN, Kim EY, Pollack SM, Combs SE, Nyflot MJ (2019) MRI radiomic features are independently associated with overall survival in soft tissue sarcoma. Adv Radiat Oncol 4(2):413–421CrossRef Spraker MB, Wootton LS, Hippe DS, Ball KC, Peeken JC, Macomber MW, Chapman TR, Hoff MN, Kim EY, Pollack SM, Combs SE, Nyflot MJ (2019) MRI radiomic features are independently associated with overall survival in soft tissue sarcoma. Adv Radiat Oncol 4(2):413–421CrossRef
12.
Zurück zum Zitat Peeken JC, Bernhofer M, Spraker MB, Pfeiffer D, Devecka M, Thamer A, Shouman MA, Ott A, Nüsslin F, Mayr NA, Rost B, Nyflot MJ, Combs SE (2019) CT-based radiomic features predict tumor grading and have prognostic value in patients with soft tissue sarcomas treated with neoadjuvant radiation therapy. Radiother Oncol 135:187–196CrossRef Peeken JC, Bernhofer M, Spraker MB, Pfeiffer D, Devecka M, Thamer A, Shouman MA, Ott A, Nüsslin F, Mayr NA, Rost B, Nyflot MJ, Combs SE (2019) CT-based radiomic features predict tumor grading and have prognostic value in patients with soft tissue sarcomas treated with neoadjuvant radiation therapy. Radiother Oncol 135:187–196CrossRef
13.
Zurück zum Zitat Zhang B, He X, Ouyang F, Gu D, Dong Y, Zhang L, Mo X, Huang W, Tian J, Zhang S (2017) Radiomic machine-learning classifiers for prognostic biomarkers of advanced nasopharyngeal carcinoma. Cancer Lett 403:21–27CrossRef Zhang B, He X, Ouyang F, Gu D, Dong Y, Zhang L, Mo X, Huang W, Tian J, Zhang S (2017) Radiomic machine-learning classifiers for prognostic biomarkers of advanced nasopharyngeal carcinoma. Cancer Lett 403:21–27CrossRef
14.
Zurück zum Zitat Ishwaran H, Kogalur U, Blackstone E, Lauer M (2008) Random survival forests. Ann Appl Stat 2:1CrossRef Ishwaran H, Kogalur U, Blackstone E, Lauer M (2008) Random survival forests. Ann Appl Stat 2:1CrossRef
15.
Zurück zum Zitat Ishwaran H, Kogalur UB, Xi C, Minn AJ (2011) Random survival forests for high-dimensional data. Stat Anal Data Min 4(1):115–132CrossRef Ishwaran H, Kogalur UB, Xi C, Minn AJ (2011) Random survival forests for high-dimensional data. Stat Anal Data Min 4(1):115–132CrossRef
16.
Zurück zum Zitat Leger S, Zwanenburg A, Pilz K, Lohaus F, Linge A, Stuschke M, Balermpas P, Rödel C, Ganswindt U, Belka C, Pigorsch S, Combs SE, Mönnich D, Zips D, Krause M, Baumann M, Troost EGC, Löck S, Richter C, Zöphel K, Kotzerke J, Schreiber A, Tinhofer I, Budach V, Sak A (2017) A comparative study of machine learning methods for time-to-event survival data for radiomics risk modelling. Sci Rep 7(1):13206CrossRef Leger S, Zwanenburg A, Pilz K, Lohaus F, Linge A, Stuschke M, Balermpas P, Rödel C, Ganswindt U, Belka C, Pigorsch S, Combs SE, Mönnich D, Zips D, Krause M, Baumann M, Troost EGC, Löck S, Richter C, Zöphel K, Kotzerke J, Schreiber A, Tinhofer I, Budach V, Sak A (2017) A comparative study of machine learning methods for time-to-event survival data for radiomics risk modelling. Sci Rep 7(1):13206CrossRef
17.
Zurück zum Zitat Nardone V, Tini P, Nioche C, Mazzei MA, Carfagno T, Battaglia G, Pastina P, Grassi R, Sebaste L, Pirtoli L (2018) Texture analysis as a predictor of radiation-induced xerostomia in head and neck patients undergoing IMRT. Radiol Med 123(6):415–423CrossRef Nardone V, Tini P, Nioche C, Mazzei MA, Carfagno T, Battaglia G, Pastina P, Grassi R, Sebaste L, Pirtoli L (2018) Texture analysis as a predictor of radiation-induced xerostomia in head and neck patients undergoing IMRT. Radiol Med 123(6):415–423CrossRef
18.
Zurück zum Zitat Ishwaran H, Kogalur UB, Gorodeski EZ, Minn AJ, Lauer MS (2010) High-dimensional variable selection for survival data. J Am Stat Assoc 105(489):205–217CrossRef Ishwaran H, Kogalur UB, Gorodeski EZ, Minn AJ, Lauer MS (2010) High-dimensional variable selection for survival data. J Am Stat Assoc 105(489):205–217CrossRef
19.
Zurück zum Zitat Schoop R, Beyersmann J, Schumacher M, Binder H (2011) Quantifying the predictive accuracy of time-to-event models in the presence of competing risks. Biom J 53(1):88–112CrossRef Schoop R, Beyersmann J, Schumacher M, Binder H (2011) Quantifying the predictive accuracy of time-to-event models in the presence of competing risks. Biom J 53(1):88–112CrossRef
20.
Zurück zum Zitat Gerds TA, Andersen PK, Kattan MW (2014) Calibration plots for risk prediction models in the presence of competing risks. Stat Med 33(18):3191–3203CrossRef Gerds TA, Andersen PK, Kattan MW (2014) Calibration plots for risk prediction models in the presence of competing risks. Stat Med 33(18):3191–3203CrossRef
21.
Zurück zum Zitat Acem I, Verhoef C, Rueten-Budde AJ, Grünhagen DJ, van Houdt WJ, van de Sande MAJ (2020) Age-related differences of oncological outcomes in primary extremity soft tissue sarcoma: a multistate model including 6260 patients. Eur J Cancer 141:128–136CrossRef Acem I, Verhoef C, Rueten-Budde AJ, Grünhagen DJ, van Houdt WJ, van de Sande MAJ (2020) Age-related differences of oncological outcomes in primary extremity soft tissue sarcoma: a multistate model including 6260 patients. Eur J Cancer 141:128–136CrossRef
22.
Zurück zum Zitat Riad S, Griffin AM, Liberman B, Blackstein ME, Catton CN, Kandel RA, O’Sullivan B, White LM, Bell RS, Ferguson PC, Wunder JS (2004) Lymph node metastasis in soft tissue sarcoma in an extremity. Clin Orthop Relat Res 426:129–134CrossRef Riad S, Griffin AM, Liberman B, Blackstein ME, Catton CN, Kandel RA, O’Sullivan B, White LM, Bell RS, Ferguson PC, Wunder JS (2004) Lymph node metastasis in soft tissue sarcoma in an extremity. Clin Orthop Relat Res 426:129–134CrossRef
23.
Zurück zum Zitat Lazarides AL, Kerr DL, Nussbaum DP, Kreulen RT, Somarelli JA, Blazer DG 3rd, Brigman BE, Eward WC (2019) Soft tissue sarcoma of the extremities: what is the value of treating at high-volume centers? Clin Orthop Relat Res 477(4):718–727CrossRef Lazarides AL, Kerr DL, Nussbaum DP, Kreulen RT, Somarelli JA, Blazer DG 3rd, Brigman BE, Eward WC (2019) Soft tissue sarcoma of the extremities: what is the value of treating at high-volume centers? Clin Orthop Relat Res 477(4):718–727CrossRef
24.
Zurück zum Zitat Coindre JM (2006) Grading of soft tissue sarcomas: review and update. Arch Pathol Lab Med 130(10):1448–1453CrossRef Coindre JM (2006) Grading of soft tissue sarcomas: review and update. Arch Pathol Lab Med 130(10):1448–1453CrossRef
25.
Zurück zum Zitat Sanmamed N, Berlin A, Beiki-Ardakani A, Ballantyne H, Simeonov A, Chung P (2018) Magnetic resonance imaging-guided brachytherapy re-irradiation for isolated local recurrence of soft tissue sarcoma. Cureus 10(4):e2457PubMedPubMedCentral Sanmamed N, Berlin A, Beiki-Ardakani A, Ballantyne H, Simeonov A, Chung P (2018) Magnetic resonance imaging-guided brachytherapy re-irradiation for isolated local recurrence of soft tissue sarcoma. Cureus 10(4):e2457PubMedPubMedCentral
26.
Zurück zum Zitat Park SY, Chung HW, Chae SY, Lee JS (2016) Comparison of MRI and PET-CT in detecting the loco-regional recurrence of soft tissue sarcomas during surveillance. Skeletal Radiol 45(10):1375–1384CrossRef Park SY, Chung HW, Chae SY, Lee JS (2016) Comparison of MRI and PET-CT in detecting the loco-regional recurrence of soft tissue sarcomas during surveillance. Skeletal Radiol 45(10):1375–1384CrossRef
27.
Zurück zum Zitat Kusunoki S, Terao Y, Ujihira T, Fujino K, Kaneda H, Kimura M, Ota T, Takeda S (2017) Efficacy of PET/CT to exclude leiomyoma in patients with lesions suspicious for uterine sarcoma on MRI. Taiwan J Obstet Gynecol 56(4):508–513CrossRef Kusunoki S, Terao Y, Ujihira T, Fujino K, Kaneda H, Kimura M, Ota T, Takeda S (2017) Efficacy of PET/CT to exclude leiomyoma in patients with lesions suspicious for uterine sarcoma on MRI. Taiwan J Obstet Gynecol 56(4):508–513CrossRef
28.
Zurück zum Zitat Lauenstein TC, Sharma P, Hughes T, Heberlein K, Tudorascu D, Martin DR (2008) Evaluation of optimized inversion-recovery fat-suppression techniques for T2-weighted abdominal MR imaging. J Magn Reson Imaging 27(6):1448–1454CrossRef Lauenstein TC, Sharma P, Hughes T, Heberlein K, Tudorascu D, Martin DR (2008) Evaluation of optimized inversion-recovery fat-suppression techniques for T2-weighted abdominal MR imaging. J Magn Reson Imaging 27(6):1448–1454CrossRef
29.
Zurück zum Zitat Amini B, Jessop AC, Ganeshan DM, Tseng WW, Madewell JE (2015) Contemporary imaging of soft tissue sarcomas. J Surg Oncol 111(5):496–503CrossRef Amini B, Jessop AC, Ganeshan DM, Tseng WW, Madewell JE (2015) Contemporary imaging of soft tissue sarcomas. J Surg Oncol 111(5):496–503CrossRef
30.
Zurück zum Zitat Fisher SM, Joodi R, Madhuranthakam AJ, Öz OK, Sharma R, Chhabra A (2016) Current utilities of imaging in grading musculoskeletal soft tissue sarcomas. Eur J Radiol 85(7):1336–1344CrossRef Fisher SM, Joodi R, Madhuranthakam AJ, Öz OK, Sharma R, Chhabra A (2016) Current utilities of imaging in grading musculoskeletal soft tissue sarcomas. Eur J Radiol 85(7):1336–1344CrossRef
31.
Zurück zum Zitat Gronchi A, Ferrari S, Quagliuolo V, Broto JM, Pousa AL, Grignani G, Basso U, Blay JY, Tendero O, Beveridge RD, Ferraresi V, Lugowska I, Merlo DF, Fontana V, Marchesi E, Donati DM, Palassini E, Palmerini E, De Sanctis R, Morosi C, Stacchiotti S, Bagué S, Coindre JM, Dei Tos AP, Picci P, Bruzzi P, Casali PG (2017) Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial. Lancet Oncol 18(6):812–822CrossRef Gronchi A, Ferrari S, Quagliuolo V, Broto JM, Pousa AL, Grignani G, Basso U, Blay JY, Tendero O, Beveridge RD, Ferraresi V, Lugowska I, Merlo DF, Fontana V, Marchesi E, Donati DM, Palassini E, Palmerini E, De Sanctis R, Morosi C, Stacchiotti S, Bagué S, Coindre JM, Dei Tos AP, Picci P, Bruzzi P, Casali PG (2017) Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial. Lancet Oncol 18(6):812–822CrossRef
32.
Zurück zum Zitat Wang H, Zhou L (2017) Random survival forest with space extensions for censored data. Artif Intell Med 79:52–61CrossRef Wang H, Zhou L (2017) Random survival forest with space extensions for censored data. Artif Intell Med 79:52–61CrossRef
33.
Zurück zum Zitat Oberije C, De Ruysscher D, Houben R, van de Heuvel M, Uyterlinde W, Deasy JO, Belderbos J, Dingemans AM, Rimner A, Din S, Lambin P (2015) A validated prediction model for overall survival from stage III non-small cell lung cancer: toward survival prediction for individual patients. Int J Radiat Oncol Biol Phys 92(4):935–944CrossRef Oberije C, De Ruysscher D, Houben R, van de Heuvel M, Uyterlinde W, Deasy JO, Belderbos J, Dingemans AM, Rimner A, Din S, Lambin P (2015) A validated prediction model for overall survival from stage III non-small cell lung cancer: toward survival prediction for individual patients. Int J Radiat Oncol Biol Phys 92(4):935–944CrossRef
34.
Zurück zum Zitat Tang XR, Li YQ, Liang SB, Jiang W, Liu F, Ge WX, Tang LL, Mao YP, He QM, Yang XJ, Zhang Y, Wen X, Zhang J, Wang YQ, Zhang PP, Sun Y, Yun JP, Zeng J, Li L, Liu LZ, Liu N, Ma J (2018) Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study. Lancet Oncol 19(3):382–393CrossRef Tang XR, Li YQ, Liang SB, Jiang W, Liu F, Ge WX, Tang LL, Mao YP, He QM, Yang XJ, Zhang Y, Wen X, Zhang J, Wang YQ, Zhang PP, Sun Y, Yun JP, Zeng J, Li L, Liu LZ, Liu N, Ma J (2018) Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study. Lancet Oncol 19(3):382–393CrossRef
35.
Zurück zum Zitat Akai H, Yasaka K, Kunimatsu A, Nojima M, Kokudo T, Kokudo N, Hasegawa K, Abe O, Ohtomo K, Kiryu S (2018) Predicting prognosis of resected hepatocellular carcinoma by radiomics analysis with random survival forest. Diagn Interv Imaging 99(10):643–651CrossRef Akai H, Yasaka K, Kunimatsu A, Nojima M, Kokudo T, Kokudo N, Hasegawa K, Abe O, Ohtomo K, Kiryu S (2018) Predicting prognosis of resected hepatocellular carcinoma by radiomics analysis with random survival forest. Diagn Interv Imaging 99(10):643–651CrossRef
36.
Zurück zum Zitat Wang L, Dong T, Xin B, Xu C, Guo M, Zhang H, Feng D, Wang X, Yu J (2019) Integrative nomogram of CT imaging, clinical, and hematological features for survival prediction of patients with locally advanced non-small cell lung cancer. Eur Radiol 29(6):2958–2967CrossRef Wang L, Dong T, Xin B, Xu C, Guo M, Zhang H, Feng D, Wang X, Yu J (2019) Integrative nomogram of CT imaging, clinical, and hematological features for survival prediction of patients with locally advanced non-small cell lung cancer. Eur Radiol 29(6):2958–2967CrossRef
37.
Zurück zum Zitat Gittleman H, Lim D, Kattan MW, Chakravarti A, Gilbert MR, Lassman AB, Lo SS, Machtay M, Sloan AE, Sulman EP, Tian D, Vogelbaum MA, Wang TJC, Penas-Prado M, Youssef E, Blumenthal DT, Zhang P, Mehta MP, Barnholtz-Sloan JS (2017) An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG oncology RTOG 0525 and 0825. Neuro-Oncol 19(5):669–677PubMed Gittleman H, Lim D, Kattan MW, Chakravarti A, Gilbert MR, Lassman AB, Lo SS, Machtay M, Sloan AE, Sulman EP, Tian D, Vogelbaum MA, Wang TJC, Penas-Prado M, Youssef E, Blumenthal DT, Zhang P, Mehta MP, Barnholtz-Sloan JS (2017) An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG oncology RTOG 0525 and 0825. Neuro-Oncol 19(5):669–677PubMed
38.
39.
Zurück zum Zitat Yasaka K, Akai H, Mackin D, Court L, Moros E, Ohtomo K, Kiryu S (2017) Precision of quantitative computed tomography texture analysis using image filtering: A phantom study for scanner variability. Medicine (Baltimore) 96(21):e6993CrossRef Yasaka K, Akai H, Mackin D, Court L, Moros E, Ohtomo K, Kiryu S (2017) Precision of quantitative computed tomography texture analysis using image filtering: A phantom study for scanner variability. Medicine (Baltimore) 96(21):e6993CrossRef
Metadaten
Titel
Prognosis prediction of extremity and trunk wall soft-tissue sarcomas treated with surgical resection with radiomic analysis based on random survival forest
verfasst von
Yuhan Yang
Xuelei Ma
Yixi Wang
Xinyan Ding
Publikationsdatum
18.05.2021
Verlag
Springer International Publishing
Erschienen in
Updates in Surgery / Ausgabe 1/2022
Print ISSN: 2038-131X
Elektronische ISSN: 2038-3312
DOI
https://doi.org/10.1007/s13304-021-01074-8

Weitere Artikel der Ausgabe 1/2022

Updates in Surgery 1/2022 Zur Ausgabe

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Wie sieht der OP der Zukunft aus?

04.05.2024 DCK 2024 Kongressbericht

Der OP in der Zukunft wird mit weniger Personal auskommen – nicht, weil die Technik das medizinische Fachpersonal verdrängt, sondern weil der Personalmangel es nötig macht.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Recycling im OP – möglich, aber teuer

02.05.2024 DCK 2024 Kongressbericht

Auch wenn sich Krankenhäuser nachhaltig und grün geben – sie tragen aktuell erheblich zu den CO2-Emissionen bei und produzieren jede Menge Müll. Ein Pilotprojekt aus Bonn zeigt, dass viele Op.-Abfälle wiederverwertet werden können.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.